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ABSTRACT
Objective: The diagnosis of muscular lesions suffered by
athletes is usually made by clinical criteria combined with
imaging of the lesion (ultrasonography and/or magnetic
resonance) and blood tests to detect the presence of non-
specific muscle markers. This study was undertaken to
evaluate injury to fast and slow-twitch fibres using
specific muscle markers for these fibres.
Methods: Blood samples were obtained from 51 non-
sports people and 38 sportsmen with skeletal muscle
injury. Western blood analysis was performed to
determine fast and slow myosin and creatine kinase (CK)
levels. Skeletal muscle damage was diagnosed by
physical examination, ultrasonography and magnetic
resonance and biochemical markers.
Results: The imaging tests were found to be excellent for
detecting and confirming grade II and III lesions. However,
gradeIlesionswereoftenunconfirmedbythesetechniques.
Grade I lesions have higher levels of fast myosin than slow
myosin with a very small increase in CK levels. Grade II and
III lesions have high values of both fast and slow myosin.
Conclusions: The evaluation of fast and slow myosin in
the blood 48 h after the lesion occurs is a useful aid for
the detection of type I lesions in particular, since fast
myosin is an exclusive skeletal muscle marker. The
correct diagnosis of grade I lesions can prevent
progression of the injury in athletes undergoing continual
training sessions and competitions, thus aiding sports
physicians in their decision making.
Muscle is sensitive to the protocols of contraction
and work to which it is submitted, since its
structure is designed to support these protocols
and to adapt to new situations of force. However,
if the integrity is affected to a greater or lesser
extent by overload, tears occur which are known as
muscle lesions. These lesions can result in incapa-
city to continue exertion of the force.
Extenuating unaccustomed exercise and high-
force eccentric action leads to skeletal muscle
damage with changes in muscle structure and
function. It induces damage to muscle fibre
membranes,
12myofibrillar disruption
3 and sarco-
plasmic reticulum vacuolisation.
4 Such exercise-
induced muscle damage activates a cascade of
reactions that result in activated skeletal muscle
protein metabolism. The protease calpain is acti-
vated immediately after exercise. Calpain initiates
the metabolic turnover of myofibrillar proteins by
releasing them from their filamentous structure.
5
Although calpain does not degrade actin and
myosin, it contributes to their release.
6 This allows
the detection of such proteins in peripheral blood
after cleavage, using specific assays such as
troponin I (TnI) and myosin heavy chains
(MHC).
78Sorichter et al
9 described the features of
an ideal marker of skeletal muscle fibre injury. One
of these was that the marker should be absolutely
muscle fibre-specific to allow reliable diagnosis of
skeletal fibre type injury. None of the markers
analysed by these authors is muscle type-specific.
The markers normally used include creatine
kinase (CK), heart-fatty acid binding protein,
myoglobin, TnI and a-actin.
10 However, in addition
to not being totally specific for skeletal muscle, they
reach a maximum value before 10 h have elapsed
after the origin of the lesion and decrease to a
considerable extent within 24 h. Most lesions occur
during holidays, so it is very easy for these 10–12
critical hours to pass before the patient is examined.
New lesions are often not accompanied by pain, but
adaylaterthemarkersof lowmolecularweighthave
degraded with no trace left in the serum. The
troponins are proteins that are very specific in terms
of fibre type; they are of low molecular weight but
are susceptible to being rapidly proteolysed, which
may explain their very short half-life in blood.
11
Skeletalmuscleisaheterogeneoustissuecomposed
of fibre types I and II, the proportion of which varies
with thetype of muscle and even within thedifferent
regions of a particular type of muscle.
12 Some of the
contractile proteins have different isoforms depend-
ing on the type of fibre. One of these is myosin,
which has different heavy and light isoforms
depending on whether the fibre type is fast or slow.
13
Myosin presents an ideal profile as a parameter
to study and is directly assignable to the grade of
the lesion since, because of its high molecular
weight, its appearance in blood can only be
explained by a fibre lesion. Fast myosin is
characteristic of fast skeletal muscle only, while
slow myosin is common to skeletal and cardiac
muscle. The level of slow myosin in the blood has
been measured by Schiaffino and Reggiani
14 and
reaches a maximum 48 and 72 h after the lesion.
The aim of this study is to evaluate muscle
lesions using as markers fast and slow myosins
present in the serum of athletes 48 h after suffering
a lesion. The efficiency of these markers is
compared with the detection of the lesion by
ultrasonography (US), magnetic resonance (MR)
and other traditional serum markers.
METHODS
Materials
The materials used in the study were monoclonal
anti-myosin (skeletal, fast) clone My-32 (Sigma,
Madrid, Spain), monoclonal anti-myosin (skeletal,
slow) clone NOQ7.5.4D (Sigma), agarose (Sigma),
protein A (Sigma) and loading buffer Nupage LDS
sample buffer (Novex, California, USA).
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Thirty-six sportsmen aged 18–25 years (athletes, jockeys, tennis
players, football players, basketball players and pentathletes)
who had suffered some pain and/or injury were studied. The
control group comprised 51 non-sportsmen aged 18–55 years.
Muscleinjurieswereclassifiedintothreecategoriesaccordingto
clinical findings: grade I (delayed onset muscle soreness and
elongation, very small muscle tear); grade II (fibrillar disruption,
moderate muscle tear); grade III (fibre disruption, evident muscle
tear). Two ml of blood were obtained from the 51 controls and
fromtheathletes48 haftertheyhadsufferedthemuscleproblem.
Serum was used for measurement of myosin levels.
Treatment of the sample
The blood samples were obtained in a Vacutainer tube and
centrifuged at 2000g at 4uC for 10 min. The serum could be kept
at 280uC without any loss of myosin for 15 days. Serum protein
was determined by the Bradford method.
15 Myosin is present as a
blood marker at a very low concentration compared with other
serum proteins. It was therefore concentrated from the serum
sample by immunoprecipitation with A protein linked to agarose-
antibody. The pellet was resuspended with 15 ml loading buffer
(60 mM HCl-Tris, 10% glycerol, 2% SDS, 5% b-mercaptoethanol,
0.025% bromophenol blue, pH 6.8), centrifuged and warmed for
10 min to 70uC. The sample (about 25 ml) was prepared to be
carried out on Nupage Novex 3–8% Tris-acetate gels and
immunodetection. One or two fast myosin and slow myosin
standards were loaded in every gel. Electrophoresis was run in X
Cell SureLock Electrophoresis Cell (Invitrogen) at 150 V for 1 h at
room temperature. The gel was cut into strips of 761.2 cm. The
gel for immunoblot analyses was transferred to a PVDF
sequencing membrane (Immobilon PSQ Millipore) at 33 V for
70 min at room temperature.
The blots were treated with SuperBlocking buffer in PBS
(Pierce) at 0.01% to Tween 20 for 1.5 h at room temperature. One
gel was reacted with 1:90 000 anti-myosin fast monoclonal
antibody and the other with 1:150 000 anti-myosin slow
monoclonal antibody. Membranes were washed with 0.01%
Tween 20 at PBS six times for 5 min and incubated with
horseradish peroxidase conjugated rabbit anti-mouse IgG
(1:90 000) for 1 h at room temperature, followed by additional
washes (six times for5 min in 0.01% Tween 20 atPBS). Each strip
was mixed with 80 ml of a mix (1:1) of Ultra Supersignal for
5 min. Proteins were visualised by enhanced chemiluminescence
(SuperSignal West Dura Trial Kit, Pierce, Rockford, Illinois, USA).
After drying, the strips were printed on the Hyperfilm TM ECL
for 10 min. This process was prepared with two samples, one for
detecting fast myosin and the other for slow myosin.
The films were scanned with a Hewlett Packard Scanjet
5200C and quantification was done with Quantity One 1-D
(BioRad, Hercules, California, USA).
Fast and slow myosin standards
The protein standards were prepared from fast and slow rabbit
muscle (tibialis anterior for fast fibres and soleus for slow
fibres). Purified myofibrils were obtained according to the
method described by Hasten et al.
16 After carrying out this
process, myofibril suspensions of about 1 mg/ml of protein
were obtained. The suspension was denatured with the loading
buffer 1:1 v/v for 2 min at 100uC. 70 mg of protein was applied to
an acrylamide gel (7.5% T, 2.5% C) to separate the proteins. The
electrophoresis was run for 75 min at 150 V. The presence of
myosin was localised bystaining a gel with CoomassieBlue G-250
R-250 (BioRad). The bands from an undyed gel were cut and
electroluted with a commercial electroluter (BioRad Model 422)
during 60 mA, 5 h with the electrolution buffer (25 mM HCl-tris,
192 mM glycine, 0.1% SDS, pH 6.8). We obtained 0.93 mg/mlf a s t
myosin and 1.55 mg/ml of slow myosin. The myosins were diluted
with 10 mM HCl-Tris, 300 mM NaCl, 2 mM EDTA at pH 6.8.
Standards were kept in fractions of 50 mla t230uC.
Measurement of enzymatic activities
CK was determined by a Technicon DAX System autoanalyser
according to the method of Szasz et al.
17
Imaging evaluation
Echography was carried out at the Centre d’Estudis d’Alt
Rendiment Esportiu (CEARE) and in the ultrasonographic
department of the FIATC Clinic using Toshiba Medical System
ultrasonography equipment with a multifrequency probe (Just-
Vision in CEARE, PowerVision in FIATC). Magnetic resonance
studies were done atthe department of magnetic resonance of the
Coracha ´n Clinic using a Siemens Symphony device (1.5 TESS).
Both types of soundings gave results which increased in direct
proportion with the grade of the lesion. In grade I lesions US
usually shows the lesion (haematic suffusion and defect of some
Figure 1 Magnetic resonance images of different grades of muscle
lesion: (A) grade I lesion; (B) grade II lesion; (C) grade III lesion.
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oedema from the time the lesion occurs. In grade II lesions both
US and MR show oedema and fibrillar defects, and grade III
lesions show a greater defect associated with haematoma and
muscle. Both US and MR show the evolution of the lesion,
observing how the oedema disappears and fibrillar repair occurs.
Statistical analysis
The levels of the each marker in controls and subjects with
different grades of injury were compared by analysis of variance
(ANOVA); p values of ,0.05 were considered significant.
RESULTS
MR images
Figure 1 shows MR images of three different grades of muscle
lesion. Figure 1A is an axial view of a grade I lesion in the upper
part of the posterior side of the right thigh showing a zone of
muscle oedema (signal increase) transduced by a recent tear of the
biceps femoris (arrows). Figure 1B is an axial view of a grade II
lesion in the medial-distal part of the posterior side of the left
thigh showing an area of oedema (signal increase) and fibrillar
defect transduced by a recent lesion in the long head of the biceps
femoris (arrows). In the coronal view of a grade III lesion of the
distal part of the anterior side of the thigh shown in fig 1C, a large
area of oedema (signal increase) and extensive fibrillar defect of
the rectus femoris can be seen in the distal part (arrows).
US images
Figure 2 shows the US appearance of the lesions shown in fig 1.
Figure 2A is a transverse section of a grade I lesion showing the
area of fibrillar defect located between the biceps femoris and the
semitendinous. The transverse section of a grade II lesion shown
in fig 2B shows the most extensive area of the fibrillar defect and
haematic suffusion in the long head of the biceps femoris. The US
appearance of a longitudinal section of a grade III lesion in fig 2C
shows complete muscle defect of the rectus femoris (arrows).
Clinical diagnosis, marker enzymes and myosin in normal and
injured muscles
Table 1 shows normal serum values of the control group and of
the athletes with different grades of muscle lesions. Our results
indicate that, in the normal state, the concentration of fast and
slow myosins in blood did not exceed 1000 mg/ml fast myosin
and 2000 mg/ml slow myosin, showing a fast/slow ratio of 0.3.
The patients diagnosed with grade I lesions, which were not
imaged by US or MR, had high levels of fast myosin (greater
than slow myosin), showing a fast/slow ratio of .2. CK levels
were almost within the limits of normality. In grade II and III
lesions, which were diagnosed by US and MR, an increase in
both fast and slow myosins was observed with a fast/slow ratio
near to 1. The concentration of slow myosin compared with
fast myosin increased in direct proportion to the severity of the
lesion. CK levels also increased in the same direction as the
severity of the muscle lesion, which suggests that it is a
particularly good marker for grade II and III lesions.
DISCUSSION
Human muscles are made up of a mixture of slow and fast fibres
with approximately 50% of each. This is different from animals,
some of which have 90% of fast fibres and some up to 90% of
slow fibres. The vastus lateralis of young Caucasian athletes
aged 15–18 years has 36.5% slow-type fibres and 63.5%
fast-type fibres and, of these, 52.3% are type IIa, 8.1% type
IIb and 3.1% type IIc.
18 The existence of mixed muscles in
humans means that lesions allow the entrance of both slow and
fast myosins into the blood. However, due to the fact that
resistance to lesions and to fatigue in the two types of fibres is not
the same, the level of slow or fast myosin heavy chain (MHC) in
the blood depends on the type of fibre damaged. In general, fast
fibres are more easily fatigued and are more sensitive to the lesion.
We can therefore expect that fast fibres release fast MHC before
slow fibres in the face of less intense exercise. Slow MHCs will
flow under more fatiguing conditions and their presence in the
blood will probably indicate a more important lesion.
On the other hand, the presence of fast MHC in blood signals
the fact that only skeletal muscle is affected and thus
constitutes an absolutely specific marker. The presence of slow
Figure 2 Ultrasonographic appearance of different grades of muscle
lesion: (A) grade I lesion; (B) grade II lesion; (C) grade III lesion.
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or heart muscle. However, given the fact that the subjects of
this study were athletes in whom a cardiac lesion is ruled out,
the detection of slow MHC in blood would act as a marker of a
slow fibre lesion with the consequences that this information
would be able to contribute.
We have developed a method to detect myosins in blood
based on specific recognition by fast and slow myosin
antibodies. We studied a group of athletes involved in different
sports who presented with muscle pain. The patients under-
went a medical examination, US, MR and blood tests including
measurement of CK levels (used as a usual muscle marker) and
slow and fast myosins. We also studied 51 people who did not
practise any sport either sporadically or for pleasure and who
were categorised as normal.
Our results indicate that, 48 h after the onset of the muscle
problem, CK activity showed a small increase in grade I lesions.
Only fast myosin is a marker with very high values, suggesting
that grade I lesions are mainly produced in type II fibres. The
results of US and MR in grade I lesions are confusing in some
cases, with negative or positive results that fail to assure total
recognition of the lesion. US and MR in grade II and grade III
lesions were highly effective in detecting the lesions.
In grade II lesions measurement of the serum markers showed
an increase in CK activity, with the greatest increases being
those of both types of myosin, reaching up to 10 times the
normal value in some cases. Grade III lesions were well detected
by CK activity and also by both types of myosin.
We conclude that the use of fast myosin provides a highly
sensitive marker for grade I lesions, at least equal to MR and
better than US and clinical diagnosis. Fast myosin is a totally
specific marker for skeletal muscle, a property not shared by any
of the markers currently in use such as CK and myoglobins.
Myosin also has the advantage of being more sensitive and more
stable in blood, since its maximum level is reached 48 h after the
lesion and it remains in the blood for longer so that it is easier to
use in diagnoses not carried out immediately and can be used to
follow the development of the muscle lesion. We therefore
conclude that the determination of fast and slow myosins is a
useful aid in the diagnosis of muscle lesions, especially for those
that are difficult to detect by other procedures.
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Commentary
The detection and diagnosis of muscle lesions in sportsmen and
sportswomen is usually performed by medical examination,
imaging techniques and laboratory tests for blood analysis.
Imaging techniques are excellent for detecting and confirming
grade II and grade III lesions but they give ambiguous results in
some cases of grade I lesions. On the other hand, laboratory
tests for blood analysis routinely determine creatine kinase and
myoglobin as markers for injury. However, the cytosolic
proteins do not necessarily reflect the amount of structural
damage suffered by the muscle fibre. Hence, the potential of
structurally-bound proteins as markers of muscle damage needs
to be investigated. The authors show that fast and slow
myosins are good markers for muscle lesions; in addition to their
muscle fibre specificity, favourable time course for muscle
release and stability in blood, serum levels of fast myosin
provide a very sensitive marker for grade I lesions.
A Megias Universidad Complutense, Madrid, Spain; amegias@solea.quim.ucm.es
Table 1 Comparison of results obtained by different methods for diagnosis of muscle injuries
Diagnosis No of samples US MR CK (U/l) Fast myosin (mg/l) Slow myocin (mg/l) Fast/slow ratio
Normal 51 – – 102 (8) 625 (62) 1535 (166) 0.3
Grade I 12 (2)o( +) – 202 (22) 2880 (159) 1281 (197) 2.2
Grade II 16 ++ ++ 482 (47) 3432 (402) 3722 (700) 0.9
Grade III 10 +++ +++ 739 (245) 8055 (2200) 6518 (124) 1.2
Data are expressed as mean (SE).
US, ultrasonography; MR, magnetic resonance; CK, creatine kinase.
Statistical ANOVA was found to be very significant for every parameter (p,0.001).
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